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background:  Prospective studies evaluating the use of Fractional Flow Reserve (FFR) for clinical decision-making in indeterminate unprotected 
left main coronary artery (ULMCA) stenosis have been limited by small sample size. We performed a pooled meta-analysis of all available studies to 
define the long term outcomes in these patients.
Methods:  Six prospective cohort studies involving 525 patients met the inclusion criteria. Patients underwent revascularization (revasc group) or 
medical therapy (deferred group) based on an FFR cut point of 0.80. The primary outcomes were all-cause mortality and major event free survival 
(defined as death, MI and revascularization). A pooled effect size for each group and odds ratios were calculated using a fixed effects model.
results:  Based on the FFR results, revascularization was undertaken in 217 patients (41%) and deferred in 308 (58%) of the patients (Figure 
1). The overall survival in the deferred group was 96% and was 89% in the revasc group. There was a trend towards overall improved survival in the 
deferred group (OR: 0.51, 95% CI: 0.25 - 1.00,p=0.05) and a non-statistically significant trend towards improved event-free survival in the revasc 
group (OR: 1.5, 95% CI: 0.9 - 2.4, p=0.08)
conclusion:  For patients with indeterminate ULMCA stenosis, deferral of revascularization based on assessment by FFR appears to be safe. 
